📰 Spinethera Inc News
Spinethera Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Spinethera Inc. Real-time updates on events, politics, business and more.
September 7, 2023
PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a leading clinical-stage pharmaceutical company specializing in innovative injectable drugs, is thrilled to announce groundbreaking results from an independent market research study. The study underscores the enormous potential of SpineThera's SX600, a novel formul...
June 9, 2023
Major players in the chronic lower back pain market are Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals Plc., Merck...
February 15, 2023
/PRNewswire/ -- Allied Market Research published a report, titled, "Sciatica Treatment Market by Type (Acute sciatica, Chronic sciatica, Others), by Drug class...
December 8, 2022
PLYMOUTH, Minn.--(BUSINESS WIRE)--SpineThera, Inc., a privately held, clinical-stage pharmaceutical company focused on the development of SX600 (a novel formulation of extended-release dexamethasone microspheres for transforaminal epidural injection [TF-EI] for the management of sciatica pain) today announced promis...
October 13, 2022
VANCOUVER, BC, Oct. 13, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research titled "Lower Back Pain Market" guarantees one will remain better informed than the competition.
May 16, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.